Lexaria Bioscience Corp Stock Total Asset
Lexaria Bioscience Corp fundamentals help investors to digest information that contributes to Lexaria Bioscience's financial success or failures. It also enables traders to predict the movement of Lexaria OTC Stock. The fundamental analysis module provides a way to measure Lexaria Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lexaria Bioscience otc stock.
Lexaria |
Lexaria Bioscience Corp OTC Stock Total Asset Analysis
Lexaria Bioscience's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Lexaria Bioscience Total Asset | 331 K |
Most of Lexaria Bioscience's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lexaria Bioscience Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Lexaria Bioscience Corp has a Total Asset of 331 K. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The total asset for all United States stocks is 100.0% higher than that of the company.
Lexaria Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lexaria Bioscience's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Lexaria Bioscience could also be used in its relative valuation, which is a method of valuing Lexaria Bioscience by comparing valuation metrics of similar companies.Lexaria Bioscience is currently under evaluation in total asset category among related companies.
Lexaria Fundamentals
| Return On Equity | -164.27 | |||
| Return On Asset | -87.72 | |||
| Current Valuation | 21.27 M | |||
| Shares Outstanding | 89.59 M | |||
| Shares Owned By Insiders | 0.60 % | |||
| Shares Owned By Institutions | 0.11 % | |||
| Price To Earning | (13.00) X | |||
| Price To Book | 8.99 X | |||
| Price To Sales | 48.33 X | |||
| Revenue | 384.54 K | |||
| Gross Profit | 276.93 K | |||
| EBITDA | (3.75 M) | |||
| Net Income | (3.93 M) | |||
| Cash And Equivalents | 1.31 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 156.1 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 8.52 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (2.66 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 2.12 | |||
| Market Capitalization | 18.58 M | |||
| Total Asset | 331 K | |||
| Retained Earnings | (10.99 M) | |||
| Working Capital | (53 K) | |||
| Current Asset | 279 K | |||
| Current Liabilities | 332 K | |||
| Z Score | -10.1 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Lexaria OTC Stock
If you are still planning to invest in Lexaria Bioscience Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lexaria Bioscience's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |